The large EPS miss and ongoing lender covenant discussions are the dominant signals. Monitor the Q2 2026 earnings for evidence that volume growth translates to profitability and for any resolution of the debt covenant situation.
Price Chart
Executive Summary
AMS reported Q1 2026 revenue of $7.1M (+15.9% YoY), beating the $6.9M consensus, but EPS of -$0.09 was a significant miss vs the -$0.01 consensus. Gross margins improved to 18.2% from 15.4% and Adjusted EBITDA rose 18.4% to $1.1M, though the company remains unprofitable with a net loss of -$0.6M. The revenue beat is overshadowed by the large EPS miss and ongoing covenant discussions with its lender.
Key Financial Metrics
Key Facts
- Revenue of $7.1M beat consensus of $6.9M and grew 15.9% YoY
- EPS of -$0.09 missed consensus of -$0.01 by 800%
- Gross margin improved to 18.2% from 15.4% YoY
- Adjusted EBITDA increased 18.4% to $1.1M from $0.9M
- Net loss attributable to AMS was -$0.6M, unchanged from prior year
- Direct patient services revenue grew 30.2% to $4.1M
- Cash improved to $5.2M from $3.7M at year-end 2025
- Company continues discussions with lender regarding debt covenant waivers
- Current portion of long-term debt was $16.8M
Financial Impact
EPS miss of -$0.08 vs consensus on a $11M market cap is material; revenue beat of ~$0.2M is modest
Risk Factors
- Debt covenant non-compliance could trigger acceleration or restructuring
- Continued operating losses despite revenue growth
- High leverage with $16.8M current debt vs $5.2M cash
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-016933 |
| Document: asha20260513_8k.htm | 0001437749-26-016933 |
| Document: 0001437749-26-016933-index-headers.html | 0001437749-26-016933 |
| Document: 0001437749-26-016933-index.html | 0001437749-26-016933 |
| Document: 0001437749-26-016933.txt | 0001437749-26-016933 |
| 8-K Data (Synthetic) | 0001437749-26-016933 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 10w ago | 8-K | $1.60 $1.47 | ▼ −7.84% | ▼ −6.10% | $1.27 (−20.63%) |
Jul 28, 2026 13w ago | 8-K | $1.53 $1.51 | ▲ +1.31% | ▲ +6.33% | $1.27 (+16.99%) |
Jun 30, 2026 17w ago | 8-K | $1.58 $1.54 | ▼ −2.53% | ▼ −1.50% | $1.27 (−19.62%) |
May 14, 2026 23w ago | 8-K | $1.58 $1.42 | ▲ +10.13% | ▲ +9.27% | $1.27 (+19.62%) |
May 14, 2026 23w ago | Press Release | $1.58 $1.42 | ▼ −10.13% | ▼ −9.27% | $1.27 (−19.62%) |
May 7, 2026 24w ago | DEFA14A | $2.01 $1.37 | ▼ −31.84% | ▼ −34.98% | $1.27 (−36.82%) |
Apr 30, 2026 25w ago | DEFA14A | $1.45 $1.64 | ▲ +13.10% | ▲ +8.14% | $1.27 (−12.41%) |
Apr 24, 2026 26w ago | 8-K | $1.32 $1.35 | ▼ −2.27% | ▲ +2.68% | $1.27 (+3.79%) |
Mar 31, 2026 30w ago | 8-K | $1.45 $1.34 | ▲ +7.59% | ▲ +17.01% | $1.27 (+12.41%) |
Mar 31, 2026 30w ago | Press Release | $1.45 $1.34 | ▲ +7.59% | ▲ +17.01% | $1.27 (+12.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers